Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
about
Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approachStrategies for the prevention of catheter-related bladder discomfort: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.Medical management of overactive bladderAn overview of the clinical use of antimuscarinics in the treatment of overactive bladderApproach to urinary incontinence in women. Diagnosis and management by family physicians.Oxybutynin: an overview of the available formulationsClinical pharmacology of old age syndromesUrologic medications and ophthalmologic side effects: a review.M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors.Sacral nerve stimulation for urinary urge incontinence, urgency-frequency, urinary retention, and fecal incontinence: an evidence-based analysis.Management of overactive bladder syndromeAgents for treatment of overactive bladder: a therapeutic class review.Overactive bladder - 18 years - Part IIPharmacologic management of overactive bladder.Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.Social, economic, and health utility considerations in the treatment of overactive bladder.Oxybutynin extended release for the management of overactive bladder: a clinical review.Behavioral intervention versus pharmacotherapy or their combinations in the management of overactive bladder dysfunction.Comparison between ketamine and hyoscine for the management of postoperative catheter-related bladder discomfort: A randomized controlled double-blind studyAdverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.Treatment of the overactive bladder: where we stand in 2003.The efficacy of resiniferatoxin in prevention of catheter related bladder discomfort in patients after TURP - a pilot, randomized, open studyOveractive Bladder Syndrome: Evaluation and Management.
P2860
Q28742444-DFC2508A-84C2-421C-B00E-27D7295BC4B0Q33595364-52C8EFD6-CF3D-4F5B-8B01-687C7A6D4401Q34124065-164B2CE8-0F7E-4FB0-AE2A-5FEE47F32782Q35042575-96DFE23E-F71D-477D-991E-4E34E781EEEAQ35146953-0B58DFF0-5ABC-4E0B-8EDB-A0A713575D05Q35166777-911CAB06-5DF9-4B75-9369-B612DC34F29AQ35200049-38565C9B-E405-4689-9DFF-ACB16E88C16BQ35788323-D57C7178-C24E-43A8-A3DF-1E9C310EE1FFQ35801020-6202887D-D911-4C3B-AFCC-6FD3D24D5BE3Q36056222-F02D525A-1CBE-4874-98B6-C712A658A720Q36875672-0BC1FE8C-F881-40B5-8DC2-4E6004DAEE36Q36885443-9765C0C1-2BE9-4C76-9F2E-5534DF4BB429Q36912766-17BEF53E-B8A8-4B1B-8BA7-6E2C6530E577Q37017434-03E12640-AB29-4150-8B1E-5B8D8CF3FBBBQ37119868-1CB5459D-CF3A-4B8E-9FC4-A515DBDD41F9Q37187453-655E6790-9C82-4BF4-950F-C2FCAAAC0EDBQ37283547-23595969-1401-447E-915E-62FF82AC9327Q37403203-34D2B5BF-75D8-4D16-A261-6CEEDFE2948DQ37484824-C6820053-45E1-4261-86FD-DCA7A5103A5AQ38835049-A020B154-9D7C-4047-8562-D8FF6A24BA95Q39020998-2D52A52D-E3CF-4543-8EFD-F095A76265C5Q39345918-FF2AE064-1E04-49E0-BE28-A674D453A666Q41774563-282A36B4-25D2-4D60-91CA-2906DB1AF7DDQ53945500-1BB8B3B4-22D9-457F-820F-32DF4BA41C39
P2860
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Prospective randomized control ...... : results of the OBJECT Study.
@en
Prospective randomized control ...... : results of the OBJECT Study.
@nl
type
label
Prospective randomized control ...... : results of the OBJECT Study.
@en
Prospective randomized control ...... : results of the OBJECT Study.
@nl
prefLabel
Prospective randomized control ...... : results of the OBJECT Study.
@en
Prospective randomized control ...... : results of the OBJECT Study.
@nl
P2093
P1476
Prospective randomized control ...... r: results of the OBJECT Study
@en
P2093
D Albrecht
D R Staskin
D Saltzstein
Overactive Bladder: Judging Effective Control and Treatment Study Group
R A Appell
P304
P407
P577
2001-04-01T00:00:00Z